FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder - FDA Press Releases

FDA approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder. This is the first FDA approval of a treatment for LEMS.

from Food and Drug Administration--Press Releases https://ift.tt/2P8P5S7
via IFTTT